Director, Collaboration Management, Europe, Platform Science and
Mark Wilson is Director, Collaboration Management, Europe for the pharmaceutical
development department of GlaxoSmithKline's pre-clinical development division.
responsible for the licensing and collaboration activity of the formulation department of GSK,
which operates globally and which employs approximately 10% of GSK's R&D headcount.
Mark has worked for SmithKline Beecham and GSK in a licensing role for the last seven
years and has been involved in over 100 commercial transactions and alliances.
His work for
the last 18 months has been concentrated on corporate venturing activity.
trained as an engineer and holds a Master's degree and a doctorate in chemical engineering
from the University of Leeds, in addition to an MBA from Columbia University and London